0 0 0.000867929986981083 0.000867929986981083 -0.000144654997830043 -0.000289309995660293 0.00318240995226404 0.00260378996094325
Sign Up Today X
Thanks for submitting the form.
Stockreport

Corporate Reputation of Pharma in 2023/2024: The Patient Perspective and Views of 2,500+ Patient Groups - Pharma Corporate Reputation Falls from COVID Highs [Yahoo! Finance]

Gilead Sciences, Inc. (GILD)  More Company Research Source: Yahoo! Finance
Last gilead sciences, inc. earnings: 4/30 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.gilead.com
of 2,500+ Patient Groups Worldwide" report has been added to ResearchAndMarkets.com's offering. Between November 2023 and late-February 2024, the survey collected the opinions of a record number of patient groups (2,518) from 106 countries, on the performance of the pharmaceutical industry during 2023 and early 2024. Continue reading, for details about: The headline global industry-wide results of the 2023 survey. The performance of the individual pharma companies included in the 2023 analysis. Summary of Results Industry Wide: Pharma corporate reputation falls from COVID highs Since 2011, when the analyst first launched its annual survey, pharmaceutical companies have significantly increased their efforts with patient groups worldwide, and in new therapy areas. Relations between pharma and patient groups have also matured, as patient groups seek not just funding, but more mutually-beneficial partnerships. During, and immediately after, the COVID-19 pandemic, pharma sa [Read more]
IMPACT SNAPSHOT EVENT TIME: GILD
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
 POST NEWS RANGE
%
PRICE CHANGE
PRICE CHANGE PERCENTAGE
S&P 500 (SPX)
%
 VOLUME RATIO
%
VOLUME (SHARES)
TICKS
AVG SHARES PER TRADE
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
GILD alerts
from News Quantified
GILD
NEWS
GILD
Earnings
GILD
Analyst Actions
GILD
SEC Filings
Stockreport

Corporate Reputation of Pharma in 2023/2024: The Patient Perspective and Views of 2,500+ Patient Groups - Pharma Corporate Reputation Falls from COVID Highs [Yahoo! Finance]

Gilead Sciences, Inc.  (GILD) 
More Company Research Source: Yahoo! Finance
Last gilead sciences, inc. earnings: 4/30 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.gilead.com
of 2,500+ Patient Groups Worldwide" report has been added to ResearchAndMarkets.com's offering. Between November 2023 and late-February 2024, the survey collected the opinions of a record number of patient groups (2,518) from 106 countries, on the performance of the pharmaceutical industry during 2023 and early 2024. Continue reading, for details about: The headline global industry-wide results of the 2023 survey. The performance of the individual pharma companies included in the 2023 analysis. Summary of Results Industry Wide: Pharma corporate reputation falls from COVID highs Since 2011, when the analyst first launched its annual survey, pharmaceutical companies have significantly increased their efforts with patient groups worldwide, and in new therapy areas. Relations between pharma and patient groups have also matured, as patient groups seek not just funding, but more mutually-beneficial partnerships. During, and immediately after, the COVID-19 pandemic, pharma sa [Read more]
IMPACT SNAPSHOT
EVENT TIME:
GILD
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Don't Miss Out On The Next BIG Stock Move
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
 POST NEWS RANGE
%
PRICE CHANGE
PRICE CHANGE PERCENTAGE
S&P 500 (SPX)
%
 VOLUME RATIO
%
VOLUME (SHARES)
TICKS
AVG SHARES PER TRADE
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS